OPHTHALMOLOGY

Longitudinal Changes of Fixation Stability and Location Within 24 Months in Stargardt Disease: ProgStar Report No. 16

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Longitudinal Changes of Fixation Stability and Location Within 24 Months in Stargardt Disease: ProgStar Report No. 16

Purpose Stargardt disease type 1 (STGD1) is the most common macular dystrophy. The assessment of fixation describes an important dimension of visual function, but data on its progression over time…

read more

Evaluation of the Diagnostic Performance of Swept-Source Anterior Segment Optical Coherence Tomography in Primary Angle Closure Disease

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Evaluation of the Diagnostic Performance of Swept-Source Anterior Segment Optical Coherence Tomography in Primary Angle Closure Disease

Purpose To evaluate the diagnostic performance of swept-source anterior segment optical coherence tomography (SS-OCT) in differentiating eyes with primary angle closure disease (PACD) from eyes of control subjects, as well…

read more

Ocular Biometric Characteristics Measured by Swept-Source Optical Coherence Tomography in Individuals Undergoing Cataract Surgery

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Ocular Biometric Characteristics Measured by Swept-Source Optical Coherence Tomography in Individuals Undergoing Cataract Surgery

Purpose To study the distribution of ocular biometric parameters using a swept-source optical coherence tomography (SS-OCT) biometer in adult candidates for cataract surgery. Design A retrospective cross-sectional study. Methods This…

read more

Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Long-Term Analysis of Clinical Features and Treatment Outcomes of Inflammatory Choroidal Neovascularization

Highlights • The overall visual outcome of inflammatory choroidal neovascularization (CNV) was relatively good, and the recurrence of inflammatory CNV showed higher rates over time after anti-VEGF treatment than previously…

read more

Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration

HIGHLIGHTS • Retinal fluid and vision outcomes were assessed in patients with neovascular age-related macular degeneration who were treated with ranibizumab. • Vision gains were greater in eyes with residual…

read more

Outcomes of Eyes With Diabetic Macular Edema That Are Lost to Follow-up After Anti–Vascular Endothelial Growth Factor Therapy

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Outcomes of Eyes With Diabetic Macular Edema That Are Lost to Follow-up After Anti–Vascular Endothelial Growth Factor Therapy

Highlights • In patients with nonproliferative diabetic retinopathy with diabetic macular edema treated with anti–vascular endothelial growth factor injections, vision was worse after being lost to follow-up for >6 months…

read more
Get Clinical Tree app for offline access